SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nurul H. M. Yusoff, Farah W. Suhaimi, Raja K. Vadivelu, Zurina Hassan, Anne Rümler, Andrea Rotter, Davide Amato, Hans C. Dringenberg, Sharif M. Mansor, Visweswaran Navaratnam, Christian P. Müller, Abuse potential and adverse cognitive effects of mitragynine (kratom), Addiction Biology, 2015, 20, 2
  2. 2
    Joanna Znaleziona, Pavlína Ginterová, Jan Petr, Peter Ondra, Ivo Válka, Juraj Ševčík, Jan Chrastina, Vítězslav Maier, Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques – a review, Analytica Chimica Acta, 2015,

    CrossRef

  3. 3
    Adarsh S. Gandhi, Ariane Wohlfarth, Mingshe Zhu, Shaokun Pang, Marisol Castaneto, Karl B. Scheidweiler, Marilyn A. Huestis, High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes, Drug Testing and Analysis, 2015, 7, 1
  4. 4
    Niels Bjerre Holm, Anders Just Pedersen, Petur Weihe Dalsgaard, Kristian Linnet, Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry, Drug Testing and Analysis, 2015, 7, 1
  5. 5
    Laurent Karila, Bruno Megarbane, Lucie Chevillard, Nadia Benturquia, Jean-Louis Laplanche, Michel Lejoyeux, Nouveaux produits de synthèse : revue des données actuelles, La Presse Médicale, 2015,

    CrossRef

  6. 6
    Folker Westphal, Frank D. Sönnichsen, Siegfried Knecht, Volker Auwärter, Laura Huppertz, Two thiazolylindoles and a benzimidazole: novel compounds on the designer drug market with potential cannabinoid receptor activity, Forensic Science International, 2015,

    CrossRef

  7. 7
    Yeter Erol Öztürk, Oya Yeter, Buket Alpertunga, Validation of JWH-018 and its metabolites in blood and urine by UPLC–MS/MS: Monitoring in forensic cases, Forensic Science International, 2015, 248, 88

    CrossRef

  8. 8
    Vadim Shevyrin, Vladimir Melkozerov, Alexander Nevero, Oleg Eltsov, Yuri Morzherin, Yuri Shafran, 3-Naphthoylindazoles and 2-naphthoylbenzoimidazoles as novel chemical groups of synthetic cannabinoids: Chemical structure elucidation, analytical characteristics and identification of the first representatives in smoke mixtures, Forensic Science International, 2014, 242, 72

    CrossRef

  9. 9
    Laura M. Huppertz, Stefan Kneisel, Volker Auwärter, Jürgen Kempf, A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization, Journal of Mass Spectrometry, 2014, 49, 2
  10. 10
    Monica Mazzarino, Xavier de la Torre, Francesco Botrè, A liquid chromatography–mass spectrometry method based on class characteristic fragmentation pathways to detect the class of indole-derivative synthetic cannabinoids in biological samples, Analytica Chimica Acta, 2014, 837, 70

    CrossRef

  11. 11
    Michael Paul, Josef Ippisch, Christian Herrmann, Susanne Guber, Wolfgang Schultis, Analysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted LC-HR-QTOFMS approach, Analytical and Bioanalytical Chemistry, 2014, 406, 18, 4425

    CrossRef

  12. 12
    Jenny L. Wiley, Timothy W. Lefever, Ricardo A. Cortes, Julie A. Marusich, Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats, Pharmacology Biochemistry and Behavior, 2014, 124, 123

    CrossRef

  13. 13
    Ashton D. Lesiak, Rabi A. Musah, Marek A. Domin, Jason R. E. Shepard, DART-MS as a Preliminary Screening Method for “Herbal Incense”: Chemical Analysis of Synthetic Cannabinoids, Journal of Forensic Sciences, 2014, 59, 2
  14. 14
    Rabi A. Musah, Robert B. Cody, Marek A. Domin, Ashton D. Lesiak, A. John Dane, Jason R.E. Shepard, DART–MS in-source collision induced dissociation and high mass accuracy for new psychoactive substance determinations, Forensic Science International, 2014, 244, 42

    CrossRef

  15. 15
    Moonhee Jang, Wonkyung Yang, Ilchung Shin, Hyeyoung Choi, Hyejin Chang, Eunmi Kim, Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse, International Journal of Legal Medicine, 2014, 128, 2, 285

    CrossRef

  16. 16
    William E. Fantegrossi, Jeffery H. Moran, Anna Radominska-Pandya, Paul L. Prather, Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?, Life Sciences, 2014, 97, 1, 45

    CrossRef

  17. 17
    Frank Musshoff, Burkhard Madea, Gerhard Kernbach-Wighton, Wolfgang Bicker, Stefan Kneisel, Melanie Hutter, Volker Auwärter, Driving under the influence of synthetic cannabinoids (“Spice”): a case series, International Journal of Legal Medicine, 2014, 128, 1, 59

    CrossRef

  18. 18
    A. Z. Temerdashev, I. M. Grigor’ev, I. V. Rybal’chenko, Evolution of new narcotic substances and methods of their determination, Journal of Analytical Chemistry, 2014, 69, 9, 817

    CrossRef

  19. 19
    Stephen M. Stout, Nina M. Cimino, Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review, Drug Metabolism Reviews, 2014, 46, 1, 86

    CrossRef

  20. 20
    R. Kronstrand, G. Thelander, D. Lindstedt, M. Roman, F. C. Kugelberg, Fatal Intoxications Associated with the Designer Opioid AH-7921, Journal of Analytical Toxicology, 2014, 38, 8, 599

    CrossRef

  21. 21
    Dana N. Harris, Stephen Hokanson, Vickie Miller, Glen P. Jackson, Fragmentation differences in the EI spectra of three synthetic cannabinoid positional isomers: JWH-250, JWH-302, and JWH-201, International Journal of Mass Spectrometry, 2014, 368, 23

    CrossRef

  22. 22
    A. Salomone, C. Luciano, D. Di Corcia, E. Gerace, M. Vincenti, Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers, Drug Testing and Analysis, 2014, 6, 1-2
  23. 23
    Nico Langer, Rainer Lindigkeit, Hans-Martin Schiebel, Ludger Ernst, Till Beuerle, Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: A snapshot of the German situation in the autumn of 2012, Drug Testing and Analysis, 2014, 6, 1-2
  24. 24
    Verena J. Koller, Volker Auwärter, Tamara Grummt, Bjoern Moosmann, Miroslav Mišík, Siegfried Knasmüller, Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8, Toxicology and Applied Pharmacology, 2014, 277, 2, 164

    CrossRef

  25. 25
    Darshan Singh, Christian P. Müller, Balasingam K. Vicknasingam, Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users, Drug and Alcohol Dependence, 2014, 139, 132

    CrossRef

  26. 26
    Anne-Laure Pélissier-Alicot, Les cannabinoïdes de synthèse : épidémiologie, modalités de consommations et effets cliniques, Toxicologie Analytique et Clinique, 2014,

    CrossRef

  27. 27
    Adarsh S Gandhi, Mingshe Zhu, Shaokun Pang, Ariane Wohlfarth, Karl B Scheidweiler, Marilyn A Huestis, Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS, Bioanalysis, 2014, 6, 11, 1471

    CrossRef

  28. 28
    V. A. Shevyrin, Yu. Yu. Morzherin, V. P. Melkozerov, A. S. Nevero, New Synthetic Cannabinoid – Methyl 2-{[1-(5-Fluoro-Pentyl)-3-Methyl-1H-Indol-3-Ylcarbonyl]-Amino}Butyrate – as a Designer Drug, Chemistry of Heterocyclic Compounds, 2014, 50, 4, 583

    CrossRef

  29. 29
    Ashton D Lesiak, Jason RE Shepard, Recent advances in forensic drug analysis by DART-MS, Bioanalysis, 2014, 6, 6, 819

    CrossRef

  30. 30
    Li Li, Ira S. Lurie, Screening of seized emerging drugs by ultra-high performance liquid chromatography with photodiode array ultraviolet and mass spectrometric detection, Forensic Science International, 2014, 237, 100

    CrossRef

  31. 31
    Jolanta B. Zawilska, Jakub Wojcieszak, Spice/K2 drugs – more than innocent substitutes for marijuana, The International Journal of Neuropsychopharmacology, 2014, 17, 03, 509

    CrossRef

  32. 32
    Vadim Shevyrin, Vladimir Melkozerov, Alexander Nevero, Oleg Eltsov, Alexander Baranovsky, Yuri Shafran, Synthetic cannabinoids as designer drugs: New representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data, Forensic Science International, 2014, 244, 263

    CrossRef

  33. 33
    Lisa K. Brents, Paul L. Prather, The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products, Drug Metabolism Reviews, 2014, 46, 1, 72

    CrossRef

  34. 34
    Daniel Taylor, Stuart G. Bowden, Reinhard Knorr, Derek R. Wilson, John Proudfoot, Anne E. Dunlop, The Pistoia Alliance Controlled Substance Compliance Service Project: from start to finish, Drug Discovery Today, 2014,

    CrossRef

  35. 35
    Luca Zamengo, Giampietro Frison, Chiara Bettin, Rocco Sciarrone, Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products, Toxicology Letters, 2014, 229, 1, 220

    CrossRef

  36. 36
    Kenji Kuwayama, Tadashi Yamamuro, Kenji Tsujikawa, Hajime Miyaguchi, Tatsuyuki Kanamori, Yuko T. Iwata, Hiroyuki Inoue, Utilization of matrix-assisted laser desorption/ionization imaging mass spectrometry to search for cannabis in herb mixtures, Analytical and Bioanalytical Chemistry, 2014, 406, 19, 4789

    CrossRef

  37. 37
    Susana Sadler Simões, Inês Silva, Antonio Castañera Ajenjo, Mário João Dias, Validation and application of an UPLC–MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market, Forensic Science International, 2014, 243, 117

    CrossRef

  38. 38
    Joel Schlatter, 2014,

    CrossRef

  39. 39
    Kratom and Other Mitragynines, 2014,

    CrossRef

  40. 40
    Rajiv Radhakrishnan, Peter H. Addy, R. Andrew Sewell, Patrick D. Skosnik, Mohini Ranganathan, Deepak Cyril D’Souza, The Effects of Drug Abuse on the Human Nervous System, 2014,

    CrossRef

  41. You have free access to this content41
    Duccio Papanti, Fabrizio Schifano, Giulia Botteon, Francesca Bertossi, Jason Mannix, Daniela Vidoni, Matteo Impagnatiello, Elisabetta Pascolo-Fabrici, Tommaso Bonavigo, “Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report, Human Psychopharmacology: Clinical and Experimental, 2013, 28, 4
  42. 42
    Bjoern Moosmann, Stefan Kneisel, Ariane Wohlfarth, Volker Brecht, Volker Auwärter, A fast and inexpensive procedure for the isolation of synthetic cannabinoids from ‘Spice’ products using a flash chromatography system, Analytical and Bioanalytical Chemistry, 2013, 405, 12, 3929

    CrossRef

  43. 43
    Maren Hermanns-Clausen, Stefan Kneisel, Bela Szabo, Volker Auwärter, Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings, Addiction, 2013, 108, 3
  44. 44
    Stefan Kneisel, Volker Auwärter, Jürgen Kempf, Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry, Drug Testing and Analysis, 2013, 5, 8
  45. 45
    Vadim Shevyrin, Vladimir Melkozerov, Alexander Nevero, Oleg Eltsov, Yuri Shafran, Analytical characterization of some synthetic cannabinoids, derivatives of indole-3-carboxylic acid, Forensic Science International, 2013, 232, 1-3, 1

    CrossRef

  46. 46
    Marion Schäffer, Thomas Gröger, Michael Pütz, Ralf Zimmermann, Assessment of the presence of damiana in herbal blends of forensic interest based on comprehensive two-dimensional gas chromatography, Forensic Toxicology, 2013, 31, 2, 251

    CrossRef

  47. 47
    Melanie Hutter, Bjoern Moosmann, Stefan Kneisel, Volker Auwärter, Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism, Journal of Mass Spectrometry, 2013, 48, 7
  48. 48
    Pierce Kavanagh, Andrej Grigoryev, Alexandra Melnik, Sergey Savchuk, Anton Simonov, Vladimir Rozhanets, Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC–MS and LC–MS/MS, Journal of Chromatography B, 2013, 934, 102

    CrossRef

  49. 49
    W. C. Rodrigues, P. Catbagan, S. Rana, G. Wang, C. Moore, Detection of Synthetic Cannabinoids in Oral Fluid Using ELISA and LC-MS-MS, Journal of Analytical Toxicology, 2013, 37, 8, 526

    CrossRef

  50. 50
    Axel Rominger, Paul Cumming, Guoming Xiong, Gabriele Koller, Stefan Förster, Andreas Zwergal, Evangelos Karamatskos, Peter Bartenstein, Christian La Fougère, Oliver Pogarell, Effects of acute detoxification of the herbal blend ‘Spice Gold’ on dopamine D2/3 receptor availability: A [18F]fallypride PET study, European Neuropsychopharmacology, 2013, 23, 11, 1606

    CrossRef

  51. 51
    Adarsh S. Gandhi, Mingshe Zhu, Shaokun Pang, Ariane Wohlfarth, Karl B. Scheidweiler, Hua-fen Liu, Marilyn A. Huestis, First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry, The AAPS Journal, 2013, 15, 4, 1091

    CrossRef

  52. 52
    Kathryn A. Seely, Amy L. Patton, Cindy L. Moran, Mary L. Womack, Paul L. Prather, William E. Fantegrossi, Anna Radominska-Pandya, Gregory W. Endres, Kermit B. Channell, Nathaniel H. Smith, Keith R. McCain, Laura P. James, Jeffery H. Moran, Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds, Forensic Science International, 2013, 233, 1-3, 416

    CrossRef

  53. 53
    Zurina Hassan, Mustapha Muzaimi, Visweswaran Navaratnam, Nurul H.M. Yusoff, Farah W. Suhaimi, Rajakumar Vadivelu, Balasingam K. Vicknasingam, Davide Amato, Stephan von Hörsten, Nurul I.W. Ismail, Nanthini Jayabalan, Ammar I. Hazim, Sharif M. Mansor, Christian P. Müller, From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction, Neuroscience & Biobehavioral Reviews, 2013, 37, 2, 138

    CrossRef

  54. 54
    Beth Emerson, Bill Durham, Jennifer Gidden, Jackson O. Lay, Gas chromatography–mass spectrometry of JWH-018 metabolites in urine samples with direct comparison to analytical standards, Forensic Science International, 2013, 229, 1-3, 1

    CrossRef

  55. 55
    Vadim Shevyrin, Vladimir Melkozerov, Alexander Nevero, Oleg Eltsov, Yuri Morzherin, Yuri Shafran, Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety, Forensic Science International, 2013, 226, 1-3, 62

    CrossRef

  56. 56
    Kazunaga Takahashi, Nahoko Uchiyama, Tomohide Fukiwake, Takashi Hasegawa, Masaaki Saijou, Yuji Motoki, Ruri Kikura-Hanajiri, Yukihiro Goda, Identification and quantitation of JWH-213, a cannabimimetic indole, as a designer drug in a herbal product, Forensic Toxicology, 2013, 31, 1, 145

    CrossRef

  57. 57
    Yujin Park, Chul Lee, Heesang Lee, Jaesung Pyo, Jiyeong Jo, Jaesin Lee, Hyeyoung Choi, Suncheun Kim, Ran Seon Hong, Yonghoon Park, Bang Yeon Hwang, Sanggil Choe, Jee H. Jung, Identification of a new synthetic cannabinoid in a herbal mixture: 1-butyl-3-(2-methoxybenzoyl)indole, Forensic Toxicology, 2013, 31, 2, 187

    CrossRef

  58. 58
    Adolfo Gregori, Fabio Damiano, Maurizio Bonavia, Valentina Mileo, Francesco Varani, Maria Monfreda, Identification of two cannabimimetic compounds WIN48098 and AM679 in illegal products, Science & Justice, 2013, 53, 3, 286

    CrossRef

  59. 59
    Amy L. Patton, Krishna C. Chimalakonda, Cindy L. Moran, Keith R. McCain, Anna Radominska-Pandya, Laura P. James, Charles Kokes, Jeffery H. Moran, K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure, Journal of Forensic Sciences, 2013, 58, 6
  60. 60
    Stephen J. Bright, Brian Bishop, Robert Kane, Ali Marsh, Monica J. Barratt, Kronic hysteria: Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm, International Journal of Drug Policy, 2013, 24, 3, 231

    CrossRef

  61. 61
    Donata Favretto, Jennifer P. Pascali, Franco Tagliaro, New challenges and innovation in forensic toxicology: Focus on the “New Psychoactive Substances”, Journal of Chromatography A, 2013, 1287, 84

    CrossRef

  62. 62
    Amber Sanders, John M. Stogner, Bryan Lee Miller, Perception vs. Reality: An Investigation of the Misperceptions Concerning the Extent of Peer Novel Drug Use, Journal of Drug Education, 2013, 43, 2, 97

    CrossRef

  63. 63
    Ana de Castro, Beatriz Piñeiro, Elena Lendoiro, Angelines Cruz, Manuel López-Rivadulla, Quantification of selected synthetic cannabinoids and Δ9-tetrahydrocannabinol in oral fluid by liquid chromatography–tandem mass spectrometry, Journal of Chromatography A, 2013, 1295, 99

    CrossRef

  64. 64
    Nerea Ferreirós, Recent advances in LC–MS/MS analysis of Δ9-tetrahydrocannabinol and its metabolites in biological matrices, Bioanalysis, 2013, 5, 21, 2713

    CrossRef

  65. 65
    Marek Dziadosz, Jens-Peter Weller, Michael Klintschar, Jörg Teske, Scheduled multiple reaction monitoring algorithm as a way to analyse new designer drugs combined with synthetic cannabinoids in human serum with liquid chromatography–tandem mass spectrometry, Journal of Chromatography B, 2013, 929, 84

    CrossRef

  66. 66
    L Cornara, B Borghesi, C Canali, M Andrenacci, M Basso, S Federici, M Labra, Smart drugs: green shuttle or real drug?, International Journal of Legal Medicine, 2013, 127, 6, 1109

    CrossRef

  67. 67
    Max Spaderna, Peter H. Addy, Deepak Cyril D’Souza, Spicing things up: synthetic cannabinoids, Psychopharmacology, 2013, 228, 4, 525

    CrossRef

  68. 68
    Samuel D. Banister, Shane M. Wilkinson, Mitchell Longworth, Jordyn Stuart, Nadine Apetz, Katrina English, Lance Brooker, Catrin Goebel, David E. Hibbs, Michelle Glass, Mark Connor, Iain S. McGregor, Michael Kassiou, The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse, ACS Chemical Neuroscience, 2013, 4, 7, 1081

    CrossRef

  69. 69
    Pierce Kavanagh, Andrej Grigoryev, Sergey Savchuk, Irina Mikhura, Andrew Formanovsky, UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products, Drug Testing and Analysis, 2013, 5, 8
  70. 70
    A. Arntson, B. Ofsa, D. Lancaster, J. R. Simon, M. McMullin, B. Logan, Validation of a Novel Immunoassay for the Detection of Synthetic Cannabinoids and Metabolites in Urine Specimens, Journal of Analytical Toxicology, 2013, 37, 5, 284

    CrossRef

  71. 71
    Volker Auwärter, Paul I. Dargan, David M. Wood, Novel Psychoactive Substances, 2013,

    CrossRef

  72. 72
    Erik W. Gunderson, Heather M. Haughey, Nassima Ait-Daoud, Amruta S. Joshi, Carl L. Hart, “Spice” and “K2” Herbal Highs: A Case Series and Systematic Review of the Clinical Effects and Biopsychosocial Implications of Synthetic Cannabinoid Use in Humans, The American Journal on Addictions, 2012, 21, 4
  73. 73
    Christopher O. Hoyte, Jeena Jacob, Andrew A. Monte, Mohammed Al-Jumaan, Alvin C. Bronstein, Kennon J. Heard, A Characterization of Synthetic Cannabinoid Exposures Reported to the National Poison Data System in 2010, Annals of Emergency Medicine, 2012, 60, 4, 435

    CrossRef

  74. 74
    Ryan Vandrey, Kelly E. Dunn, Jeannie A. Fry, Elizabeth R. Girling, A survey study to characterize use of Spice products (synthetic cannabinoids), Drug and Alcohol Dependence, 2012, 120, 1-3, 238

    CrossRef

  75. 75
    Stefan Kneisel, Volker Auwärter, Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction, Journal of Mass Spectrometry, 2012, 47, 7
  76. 76
    Karoline Simolka, Rainer Lindigkeit, Hans-Martin Schiebel, Uli Papke, Ludger Ernst, Till Beuerle, Analysis of synthetic cannabinoids in “spice-like” herbal highs: snapshot of the German market in summer 2011, Analytical and Bioanalytical Chemistry, 2012, 404, 1, 157

    CrossRef

  77. 77
    Gustavo Merola, Zeineb Aturki, Giovanni D’Orazio, Rossella Gottardo, Teodora Macchia, Franco Tagliaro, Salvatore Fanali, Analysis of synthetic cannabinoids in herbal blends by means of nano-liquid chromatography, Journal of Pharmaceutical and Biomedical Analysis, 2012, 71, 45

    CrossRef

  78. 78
    Megan Grabenauer, Wojciech L. Krol, Jenny L. Wiley, Brian F. Thomas, Analysis of Synthetic Cannabinoids Using High-Resolution Mass Spectrometry and Mass Defect Filtering: Implications for Nontargeted Screening of Designer Drugs, Analytical Chemistry, 2012, 84, 13, 5574

    CrossRef

  79. 79
    Aaron B. Schneir, Todd Baumbacher, Convulsions Associated with the Use of a Synthetic Cannabinoid Product, Journal of Medical Toxicology, 2012, 8, 1, 62

    CrossRef

  80. 80
    F. Ivy Carroll, Anita H. Lewin, S. Wayne Mascarella, Herbert H. Seltzman, P. Anantha Reddy, Designer drugs: a medicinal chemistry perspective, Annals of the New York Academy of Sciences, 2012, 1248, 1
  81. 81
    J. Ammann, J. M. McLaren, D. Gerostamoulos, J. Beyer, Detection and Quantification of New Designer Drugs in Human Blood: Part 1 - Synthetic Cannabinoids, Journal of Analytical Toxicology, 2012, 36, 6, 372

    CrossRef

  82. 82
    K. G. Shanks, T. Dahn, A. R. Terrell, Detection of JWH-018 and JWH-073 by UPLC-MS-MS in Postmortem Whole Blood Casework, Journal of Analytical Toxicology, 2012, 36, 3, 145

    CrossRef

  83. 83
    Tim Sobolevsky, Ilya Prasolov, Grigory Rodchenkov, Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids, Drug Testing and Analysis, 2012, 4, 10
  84. 84
    Melanie Hutter, Stefan Kneisel, Volker Auwärter, Merja A. Neukamm, Determination of 22 synthetic cannabinoids in human hair by liquid chromatography–tandem mass spectrometry, Journal of Chromatography B, 2012, 903, 95

    CrossRef

  85. 85
    Rossella Gottardo, Anna Chiarini, Ilaria Dal Prà, Catia Seri, Claudia Rimondo, Giovanni Serpelloni, Ubaldo Armato, Franco Tagliaro, Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS, Journal of Mass Spectrometry, 2012, 47, 1
  86. 86
    Christopher D. Rosenbaum, Stephanie P. Carreiro, Kavita M. Babu, Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines, Journal of Medical Toxicology, 2012, 8, 1, 15

    CrossRef

  87. 87
    Stefan Kneisel, Folker Westphal, Philippe Bisel, Volker Brecht, Sebastian Broecker, Volker Auwärter, Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in ‘herbal incense’, Journal of Mass Spectrometry, 2012, 47, 2
  88. 88
    F. Westphal, F.D. Sönnichsen, S. Thiemt, Identification of 1-butyl-3-(1-(4-methyl)naphthoyl)indole in a herbal mixture, Forensic Science International, 2012, 215, 1-3, 8

    CrossRef

  89. 89
    Ermanno Valoti, Eleonora Casagni, Lucia Dell’Acqua, Marco Pallavicini, Gabriella Roda, Chiara Rusconi, Valentina Straniero, Veniero Gambaro, Identification of 1-butyl-3-(1-(4-methyl)naphtoyl)indole detected for the first time in “herbal high” products on the Italian market, Forensic Science International, 2012, 223, 1-3, e42

    CrossRef

  90. 90
    Karolina Sekuła, Dariusz Zuba, Roman Stanaszek, Identification of naphthoylindoles acting on cannabinoid receptors based on their fragmentation patterns under ESI-QTOFMS, Journal of Mass Spectrometry, 2012, 47, 5
  91. 91
    Barry K. Logan, Lindsay E. Reinhold, Allan Xu, Francis X. Diamond, Identification of Synthetic Cannabinoids in Herbal Incense Blends in the United States, Journal of Forensic Sciences, 2012, 57, 5
  92. 92
    Lotte A. Reitzel, Petur W. Dalsgaard, Irene B. Müller, Claus Cornett, Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish Internet company, Drug Testing and Analysis, 2012, 4, 5
  93. 93
    M. Hutter, S. Broecker, S. Kneisel, V. Auwärter, Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS/MS techniques, Journal of Mass Spectrometry, 2012, 47, 1
  94. 94
    Nahoko Uchiyama, Maiko Kawamura, Ruri Kikura-Hanajiri, Yukihiro Goda, Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products, Forensic Toxicology, 2012, 30, 2, 114

    CrossRef

  95. 95
    Rossella Gottardo, Anna Bertaso, Jennifer Pascali, Daniela Sorio, Giacomo Musile, Elisa Trapani, Catia Seri, Giovanni Serpelloni, Franco Tagliaro, Micellar electrokinetic chromatography: A new simple tool for the analysis of synthetic cannabinoids in herbal blends and for the rapid estimation of their logP values, Journal of Chromatography A, 2012, 1267, 198

    CrossRef

  96. 96
    Lisa K. Brents, Anna Gallus-Zawada, Anna Radominska-Pandya, Tamara Vasiljevik, Thomas E. Prisinzano, William E. Fantegrossi, Jeffery H. Moran, Paul L. Prather, Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity, Biochemical Pharmacology, 2012, 83, 7, 952

    CrossRef

  97. 97
    R. A. F. Couch, H. Madhavaram, Phenazepam and cannabinomimetics sold as herbal highs in New Zealand, Drug Testing and Analysis, 2012, 4, 6
  98. 98
    B. C. Ginsburg, L. R. McMahon, J. J. Sanchez, M. A. Javors, Purity of Synthetic Cannabinoids Sold Online for Recreational Use, Journal of Analytical Toxicology, 2012, 36, 1, 66

    CrossRef

  99. 99
    Yin Cheong Wong, Shuai Qian, Zhong Zuo, Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 7, 833

    CrossRef

  100. 100
    Alan Hb Wu, Roy Gerona, Patil Armenian, Deborah French, Matthew Petrie, Kara L Lynch, Role of liquid chromatography–high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology, Clinical Toxicology, 2012, 50, 8, 733

    CrossRef

  101. 101
    A. Salomone, E. Gerace, F. D'Urso, D. Di Corcia, M. Vincenti, Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples, Journal of Mass Spectrometry, 2012, 47, 5
  102. 102
    Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran, Liana Fattore, Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, 39, 2, 234

    CrossRef

  103. 103
    DANIEL CASTELLANOS, GABRIEL THORNTON, Synthetic Cannabinoid Use, Journal of Psychiatric Practice, 2012, 18, 2, 86

    CrossRef

  104. 104
    Felecia N. Jinwala, Mayank Gupta, Synthetic Cannabis and Respiratory Depression, Journal of Child and Adolescent Psychopharmacology, 2012, 22, 6, 459

    CrossRef

  105. 105
    P. Kavanagh, A. Grigoryev, A. Melnik, A. Simonov, The Identification of the Urinary Metabolites of 3-(4-Methoxybenzoyl)-1-Pentylindole (RCS-4), a Novel Cannabimimetic, by Gas Chromatography-Mass Spectrometry, Journal of Analytical Toxicology, 2012, 36, 5, 303

    CrossRef

  106. 106
    A. O. Cox, R. C. Daw, M. D. Mason, M. Grabenauer, P. G. Pande, K. H. Davis, J. L. Wiley, P. R. Stout, B. F. Thomas, J. W. Huffman, Use of SPME-HS-GC-MS for the Analysis of Herbal Products Containing Synthetic Cannabinoids, Journal of Analytical Toxicology, 2012, 36, 5, 293

    CrossRef

  107. 107
    Eric W. Klee, Henning Schneider, Karl J. Clark, Margot A. Cousin, Jon O. Ebbert, W. Michael Hooten, Victor M. Karpyak, David O. Warner, Stephen C. Ekker, Zebrafish: a model for the study of addiction genetics, Human Genetics, 2012, 131, 6, 977

    CrossRef

  108. 108
    Dariusz Zuba, Bogumila Byrska, Martyna Maciow, Comparison of “herbal highs” composition, Analytical and Bioanalytical Chemistry, 2011, 400, 1, 119

    CrossRef

  109. 109
    Kei Zaitsu, Munehiro Katagi, Keiko Nakanishi, Noriaki Shima, Hiroe Kamata, Tooru Kamata, Hiroshi Nishioka, Akihiro Miki, Michiaki Tatsuno, Tatsunori Iwamura, Takako Sato, Hitoshi Tsuchihashi, Koichi Suzuki, Comprehensive Analytical Methods of the Synthetic Cannabinoids Appearing In the Illicit Drug Market, Japanese Journal of Forensic Science and Technology, 2011, 16, 2, 73

    CrossRef

  110. 110
    Kenichi Tomiyama, Masahiko Funada, Cytotoxicity of synthetic cannabinoids found in “Spice” products: The role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line, Toxicology Letters, 2011, 207, 1, 12

    CrossRef

  111. 111
    Tiina J. Kauppila, Anu Flink, Markus Haapala, Ulla-Maija Laakkonen, Laura Aalberg, Raimo A. Ketola, Risto Kostiainen, Desorption atmospheric pressure photoionization–mass spectrometry in routine analysis of confiscated drugs, Forensic Science International, 2011, 210, 1-3, 206

    CrossRef

  112. 112
    Sebastian Dresen, Stefan Kneisel, Wolfgang Weinmann, Ralf Zimmermann, Volker Auwärter, Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples, Journal of Mass Spectrometry, 2011, 46, 2
  113. 113
    Andrej Grigoryev, Aleksandra Melnik, Sergey Savchuk, Anton Simonov, Vladimir Rozhanets, Gas and liquid chromatography–mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures, Journal of Chromatography B, 2011, 879, 25, 2519

    CrossRef

  114. 114
    Nahoko Uchiyama, Ruri Kikura-Hanajiri, Yukihiro Goda, Identification of a Novel Cannabimimetic Phenylacetylindole, Cannabipiperidiethanone, as a Designer Drug in a Herbal Product and Its Affinity for Cannabinoid CB1 and CB2 Receptors, CHEMICAL & PHARMACEUTICAL BULLETIN, 2011, 59, 9, 1203

    CrossRef

  115. 115
    Torsten Arndt, Ulrich Claussen, Brunhilde Güssregen, Stefanie Schröfel, Birgit Stürzer, Annika Werle, Gerald Wolf, Kratom alkaloids and O-desmethyltramadol in urine of a “Krypton” herbal mixture consumer, Forensic Science International, 2011, 208, 1-3, 47

    CrossRef

  116. 116
    Cindy L. Moran, Vi-Huyen Le, Krishna C. Chimalakonda, Amy L. Smedley, Felisia D. Lackey, Suzanne N. Owen, Paul D. Kennedy, Gregory W. Endres, Fred L. Ciske, James B. Kramer, Andrei M. Kornilov, L. D. Bratton, Paul J. Dobrowolski, William D. Wessinger, William E. Fantegrossi, Paul L. Prather, Laura P. James, Anna Radominska-Pandya, Jeffery H. Moran, Quantitative Measurement of JWH-018 and JWH-073 Metabolites Excreted in Human Urine, Analytical Chemistry, 2011, 83, 11, 4228

    CrossRef

  117. 117
    RECENT LITERATURE, Focus on Alternative and Complementary Therapies, 2011, 16, 2
  118. 118
    Harri Koskela, Ullastiina Hakala, Leena Loiske, Paula Vanninen, Ilmari Szilvay, Separation and structural characterization of a synthetic cannabinoid found in a herbal product using off-line LC-DAD-NMR, Analytical Methods, 2011, 3, 10, 2307

    CrossRef

  119. 119
    J. Lapoint, L. P. James, C. L. Moran, L. S. Nelson, R. S. Hoffman, J. H. Moran, Severe Toxicity Following Synthetic Cannabinoid Ingestion, Clinical Toxicology, 2011, 49, 8, 760

    CrossRef

  120. 120
    Jeffery H. Moran, Smart resource allocation needed to study 'legal highs', Nature Medicine, 2011, 17, 11, 1339

    CrossRef

  121. 121
    Krishna C. Chimalakonda, Cindy L. Moran, Paul D. Kennedy, Gregory W. Endres, Adam Uzieblo, Paul J. Dobrowolski, E. Kim Fifer, Jeff Lapoint, Lewis S. Nelson, Robert S. Hoffman, Laura P. James, Anna Radominska-Pandya, Jeffery H. Moran, Solid-Phase Extraction and Quantitative Measurement of Omega and Omega-1 Metabolites of JWH-018 and JWH-073 in Human Urine, Analytical Chemistry, 2011, 83, 16, 6381

    CrossRef

  122. 122
    Ruri Kikura-Hanajiri, Nahoko Uchiyama, Yukihiro Goda, Survey of current trends in the abuse of psychotropic substances and plants in Japan, Legal Medicine, 2011, 13, 3, 109

    CrossRef

  123. 123
    Mathias B. Forrester, Kurt Kleinschmidt, Evan Schwarz, Amy Young, Synthetic Cannabinoid Exposures Reported to Texas Poison Centers, Journal of Addictive Diseases, 2011, 30, 4, 351

    CrossRef

  124. 124
    Susanna Every-Palmer, Synthetic cannabinoid JWH-018 and psychosis: An explorative study, Drug and Alcohol Dependence, 2011, 117, 2-3, 152

    CrossRef

  125. You have free access to this content125
    Current literature in mass spectrometry, Journal of Mass Spectrometry, 2010, 45, 12
  126. 126
    Marijuana (Cannabis sativa L.) and Synthetic Cannabinoids,